• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Elevated serum tumor markers in patients with testicular cancer after induction chemotherapy due to a reservoir of markers in cystic differentiated mature teratoma.

作者信息

van der Gaast A, Hoekstra J W, Croles J J, Splinter T A

机构信息

Department of Medical Oncology, University Hospital Rotterdam-Dijkzigt, The Netherlands.

出版信息

J Urol. 1991 Apr;145(4):829-31. doi: 10.1016/s0022-5347(17)38465-3.

DOI:10.1016/s0022-5347(17)38465-3
PMID:1706441
Abstract

Elevated serum tumor markers in patients with testicular cancer after induction chemotherapy indicate in most instances the presence of residual malignant disease. We describe 2 patients with elevated tumor markers after chemotherapy and before retroperitoneal lymph node dissection who did not prove to have residual malignant disease but cystic differentiated mature teratoma with a high content of alpha-fetoprotein and beta-human chorionic gonadotropin, respectively, in the cysts. It is postulated that leakage of the contents of these cysts to the plasma compartment was responsible for maintaining elevated serum tumor marker levels. Recognition of such entities is of consequence since unnecessary salvage chemotherapy in these patients may be avoided.

摘要

相似文献

1
Elevated serum tumor markers in patients with testicular cancer after induction chemotherapy due to a reservoir of markers in cystic differentiated mature teratoma.
J Urol. 1991 Apr;145(4):829-31. doi: 10.1016/s0022-5347(17)38465-3.
2
Transient rise in tumor marker after initial adjuvant chemotherapy for testicular cancer.
Urology. 1982 Jul;20(1):50-2. doi: 10.1016/0090-4295(82)90537-4.
3
Prognosis following chemotherapy for metastatic malignant teratoma.
Br J Urol. 1987 Jun;59(6):578-83. doi: 10.1111/j.1464-410x.1987.tb04881.x.
4
Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT).改善非精原细胞瘤性生殖细胞肿瘤(NSGCT)挽救性治疗的效果。
Br J Cancer. 2000 Aug;83(4):426-30. doi: 10.1054/bjoc.2000.1290.
5
[Progress in the therapy of testicular teratoid tumors].
Wien Med Wochenschr. 1982 Jul 31;132(13-14):329-33.
6
Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer.晚期非精原细胞瘤性睾丸癌患者化疗后肿瘤残留的组织学研究。
J Urol. 1989 Nov;142(5):1239-42. doi: 10.1016/s0022-5347(17)39044-4.
7
Serum tumour marker regression rate following chemotherapy for malignant teratoma.
Eur J Cancer Clin Oncol. 1984 Dec;20(12):1463-70. doi: 10.1016/0277-5379(84)90137-8.
8
Residual masses after successful chemotherapy for testicular carcinoma.睾丸癌化疗成功后的残留肿块。
AJR Am J Roentgenol. 1986 Jun;146(6):1184-6. doi: 10.2214/ajr.146.6.1184.
9
Treatment of retroperitoneal residual tumor after PVB chemotherapy of nonseminomatous testicular tumors.
Cancer. 1986 Oct 1;58(7):1418-21. doi: 10.1002/1097-0142(19861001)58:7<1418::aid-cncr2820580706>3.0.co;2-t.
10
Transient tumor marker elevation following chemotherapy for germ cell tumors of the testis.睾丸生殖细胞肿瘤化疗后肿瘤标志物短暂升高。
Cancer Treat Rep. 1986 Nov;70(11):1329-31.

引用本文的文献

1
Human Malignant Rhabdoid Tumor Antigens as Biomarkers and Potential Therapeutic Targets.人类恶性横纹肌样瘤抗原作为生物标志物和潜在治疗靶点
Cancers (Basel). 2022 Jul 28;14(15):3685. doi: 10.3390/cancers14153685.
2
Significant biomarkers for the management of hepatocellular carcinoma.用于肝细胞癌管理的重要生物标志物。
Clin J Gastroenterol. 2015 Jun;8(3):109-15. doi: 10.1007/s12328-015-0568-9. Epub 2015 Apr 9.
3
Late recurrences of germ cell malignancies: a population-based experience over three decades.生殖细胞恶性肿瘤的晚期复发:基于人群的三十年经验。
Br J Cancer. 2006 Mar 27;94(6):820-7. doi: 10.1038/sj.bjc.6603014.
4
Monocyte activation in patients with non-seminomatous germ cell tumour of the testis before and after tumour eradication.睾丸非精原细胞瘤患者在肿瘤根除前后的单核细胞活化情况。
J Clin Pathol. 1996 May;49(5):381-5. doi: 10.1136/jcp.49.5.381.
5
Results of salvage retroperitoneal lymphadenectomy (RLA) in the treatment of patients with nonseminomatous germ cell tumours remaining marker positive after inductive chemotherapy.
Int Urol Nephrol. 1995;27(3):325-9. doi: 10.1007/BF02564770.
6
The changing role of surgery in metastatic non-seminomatous germ cell tumour.手术在转移性非精原细胞性生殖细胞肿瘤中不断变化的作用。
Br J Cancer. 1992 Jan;65(1):127-9. doi: 10.1038/bjc.1992.24.